|
Olga Anokhina,
Quality Assurance Director, Bayer Healthcare
|
|
Andrey Belashov,
CEO, Segmenta Pharm
|
|
Sergey Beloborodov,
Executive Director, NovaMedika
|
|
Nikolay Bespalov,
Development Director, RNC Pharma
|
|
Danil Blinov,
CEO, Pfizer Russia
|
|
Igor Bodyagin,
Deputy Executive Director, Union of Professional Pharmaceutical Organizations
|
|
Enrico Bovi,
Business Development Lead, Pfizer
|
|
Vasily Boytsov,
Director of technical regulation and accreditation, Eurasian Economic Commission
|
|
Valentina Buchneva,
Director, Bosnalijek (Russian Brunch)
|
|
Anton Buzdalin,
Managing Partner, Parusinvest, piluli.ru, eapteka.ru, strongbrand.ru, pharmedu.ru, medkrug.ru, oncoforum.ru, proglaza.ru
|
|
Alexander Bykov,
Director of Pharmaceutical Economic Affairs, “R-Pharm” Group of Companies
|
|
Vladislav Deigin,
CEO, “Pharma Bio”
|
|
Nikolay Demidov,
CEO, IMS
|
|
Viktor Dmitriev,
CEO, Association of the Russian Pharmaceutical Manufacturers
|
|
Oleg Feldman,
Director of Health Service Department, Synovate Comcon Healthcare
|
|
Damir Galyamov,
marketing and sales director, Pharmamed.RU
|
|
Elena Gavrilova,
Head of chemistry, biotechnology and medicine department, Federal Institute of Industrial Property of Russian Agency for Patents and Trademarks
|
|
Denis Gavrilov,
Adviser of Law Office “Egorov Puginsky Afanasiev & Partners”
|
|
Ivan Glushkov,
Deputy Director General, Stada CIS
|
|
Alexander Gorynin,
Head of business development in Russia and CIS, STADA CIS
|
|
German Inozemtsev,
Executive editor, “Pharmatsevticheskiy Vestnik”
|
|
Anton Ishchenko,
Owner, Apteki.su
|
|
Olga Karpova,
lawyer, partner, Law firm “Forward Legal”
|
|
Alexey Katkov,
Vice-president on Legal question, BioKad
|
|
Anton Katlinskiy,
CEO, “Fort”
|
|
Vladimir Khristenko,
president, Nanolek
|
|
Olga Kirtaeva,
director, Biotehnos
|
|
German Klimenko,
Internet Adviser to the President, Institute of Internet Development
|
|
Sergey Klimenko,
Head of Life Sciences Group, Pepeliaev Group
|
|
Andrey Kolokoltsov,
Deputy Chairman of the Board, Manufacturing, Business Development and Technologies, “Pharmeco”
|
|
Olga Kolotilova,
Director of the Department of Pharmaceutical and Medical Industry, Ministry of Industry and Trade of the Russian Federation
|
|
Dmitriy Kopytin,
Vice-president on Legal question, “NovaMedika”
|
|
Valentina Kosenko,
Head of the management of state quality control organization of medical products, the Federal Oversight Service for Health Care
|
|
Oksana Krasnyh,
Head of Customer Marketing Department, Materia Medica Holding
|
|
Dmitriy Kudlay,
CEO, “Generium”
|
|
Vadim Kukava,
Executive Director, InPharma Association
|
|
Alexander Kuzin,
Managing Director, NovaMedica
|
|
Boris Liparteliani,
sales and marketing manager, Akrikhin / Polpharma
|
|
Uriy Litvischenko,
CEO, Chiesi Pharmaceuticals, executive director of committee on health service and pharmacy services, Europe Business Association in Russia
|
|
Alexandr Lobakov,
Managing Partner, Novus Capital
|
|
Elena Maksimkina,
Director of the Department of Drug Supply and regulate the handling of medical products, Ministry of Health
|
|
Alexandr Malin,
CEO, Nativa
|
|
Ron Mayron,
former CEO of Teva Israel & VP Africa Turkey and CIS, Teva Pharmaceuticals
|
|
David Melik-Guseynov,
CEO, Research Institute for health organization
|
|
Dmitriy Mordvintsev,
market development director, Biokad
|
|
Vadim Muzyaev,
President, “PROTEK”
|
|
Rustem Muratov,
Chief Commercial Officer, Akrikhin
|
|
Mikhail Nekrasov,
CEO, Nanolek
|
|
Elena Nevolina,
Executive director, Union of the National pharmaceutical board
|
|
Timofey Nizhegorodtsev,
Head of social control and trade, ̉he Federal Anti-monopoly Service
|
|
Alexander Ovchinnikov,
partner, Carnegie Moscow Centre
|
|
Timofey Petrov,
CEO, Rapharma
|
|
Pierre Gilles DE PIOGER,
Primary Care Business Unit Head, Ipsen
|
|
Dmitriy Pogrebenskiy,
CEO, Protek
|
|
Larisa Popovich,
Director, Health Economics Institute
|
|
Yulia Pravosudova,
Business Development, Licensing & New Products Manager, Novartis
|
|
Inna Pugach,
Head of Laboratory Diagnostic Department, Aston Group
|
|
Evgeniy Rashchevskiy,
partner, Egorov Puginsky Afanasiev & Partners (Law office)
|
|
Iskra Reic,
CEO, AstraZeneca Russia
|
|
Vadim Ryabokon,
head of business development in Russia and the CIS, Sanofi
|
|
Georgi Sboev,
Deputy Head of the Department of Drug Supply and regulation of circulation of medical products, the Ministry of Health
|
|
Dmitry Shchekin,
Head of Coordination of forming common markets pharmaceuticals and medical devices of Department of technical regulation and accreditation, Eurasian Economic Commission
|
|
Maria Sdvizhkova,
Head of Strategic Consulting Department, Aston Group
|
|
Vladimir Semenov,
Cand.Sc., Head of Pharmacy Services Department, Federal Institute of Industrial Property of Russian Agency for Patents and Trademarks
|
|
Nikolay Semenov,
CEO, National Immunobiological Company
|
|
Anna Shibanova,
Associate, Pepeliaev Group
|
|
Sergey Shulyak,
CEO, DSM Group
|
|
Mikhail Shurigin,
Research and Innovation Director, PharmaSyntez
|
|
Tatyana Sitnova,
Director of Legal Questions, BIND RUS, LLC
|
|
Vitaliy Smerdov,
Candidate of Medical Science, Chairman of the board, PharmEco
|
|
Sergey Smirnov,
Head of Business Development and Licensing, Russia and CIS, Bayer Healthcare
|
|
Anatoliy Tentser,
development director, “Katren”
|
|
Liliya Titova,
executive director, Union of Professional Pharmaceutical Organizations
|
|
Lidiya Vasilieva,
Marketing Director, Pfizer
|
|
Marina Veldanova,
Senior Vice-President Russia and CIS operational IPSEN
|
|
Vadim Vlasov,
President, Novartis Group, Russia
|
|
Yuri Yakhin,
Head of group of intellectual property and trademarks practice, “Pepeliaev Group”
|
|
Vadim Yatsuk,
CEO, Sotex
|
|
Ekaterina Zakharova,
Board chairman, All-Russian Association of Orphan diseases
|
|
Yury Zhulev,
President, Russian Association of Hemophilia
|
|
Andrey Zolotovskiy,
Head of Investment Policy Department, the Yaroslav Region
|
|
|
